Engrail Therapeutics nabs $32m Series A
San Diego-based Engrail Therapeutics, a drug developer, has raised $32 million in Series A financing.
San Diego-based Engrail Therapeutics, a drug developer, has raised $32 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination